NEW YORK, April 8, 2021 /PRNewswire/ — ResoluteAI, the analysis platform for science, in the present day launched a set of instruments to streamline put up market surveillance and pharmacovigilance evaluation. Utilizing information accessible from OpenFDA, ResoluteAI has linked and enhanced entry to 6 FDA databases:
- FDA Antagonistic Occasion Reporting System (FAERS)
- Producer and Person Facility Gadget Expertise (MAUDE)
- Medical Gadget Recall and Enforcements
- Orange E book
- Prescription Drug Labeling Assets
- 510(okay) Premarket Notification
These databases can now be searched concurrently, making a simplified and extra environment friendly analysis, reporting, and analytical search expertise. Customers can view data collectively to raised perceive vital and related connections which will have been arduous to see in any other case.
ResoluteAI customers can apply extra analysis and analytic instruments to the FDA databases throughout their discovery course of. They’ll:
- Goal analysis via particular search classes and tags
- Apply analytics to information
- Export searches and information visualizations
- Arrange alerts on to inbox
“The FDA supplies a useful service by making its quite a few standalone datasets readily accessible. We have linked these datasets with one another together with different datasets that professionals use for put up market surveillance and pharmacovigilance,” stated Steve Goldstein, CEO of ResoluteAI. “By connecting datasets with information, educational publications, patents, and medical trials, our prospects can conduct extra complete analysis on medicine and medical units.”
ResoluteAI is the analysis platform for science. Our safe platform permits you to search aggregated scientific, regulatory, and enterprise databases concurrently. Mixed with our interactive analytics and downloadable visualizations, you can also make connections that result in breakthrough discoveries. In 2018, ResoluteAI was named Greatest Rising Firm by AI World. For extra info, go to resolute.ai.
— to www.prnewswire.com